Allergan – Allergan beat estimates by 3 cents a share, with adjusted quarterly profit of $4.38 per share. The drugmaker’s revenue beat forecasts as well, driven by strong sales of products like Botox and Juvéderm. Allergan also raised its full-year revenue forecast.
Dean Foods – The milk producer lost an adjusted 36 cents per share for its latest quarter, wider than the 13 cents a share loss expected by Wall Street. Revenue was also short of estimates, Dean pointed to dairy commodity inflation, volume pressure, and an accelerated decline in the white milk category as negative factors during the quarter.
